Lys Therapeutics secures $29m for brain therapy

French biotech pushes a single brain-protecting therapy toward the clinic, raising fresh questions about the future of neurological medicine. What if one drug could help someone rushed into the emergency room after a stroke and also slow the steady progression of Parkinson’s disease? At first glance, the idea sounds almost contradictory. Stroke is sudden, measured […] The post Lys Therapeutics secures $29m for brain therapy appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.